ISSN 0975-3583
 

Journal of Cardiovascular Disease Research



    Glycated Albumin - Biomarker for Glycaemic Control and Prognostic Factor in Chronic Kidney Disease Patients


    Ranjithkanna M, Rajesh N , Velvizhi M , Thirunavukarasu MR
    JCDR. 2023: 698-704

    Abstract

    Background: Chronic kidney disease is a public health problem of global concern. In HD patients, GA seems more reliable because it is not influenced by the erythrocyte lifespan or erythropoietin and iron therapy, so it could serve as an alternative marker for glycemic control in these patients. Efficacy for glycemic control in HD patients has not yet been firmly established because most studies have examined the correlation between GA and the mean of random serum glucose concentrations instead of continuous glucose monitoring. Aims and objectives: To assess the role of glycated albumin as a biochemical marker in glycemic control in chronic kidney disease patients (G5D) on hemodialysis.

    Description

    .

    » PDF

    Volume & Issue

    Volume 14 Issue 8

    Keywords